{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:56:48Z","timestamp":1793174208450,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R00HL121087"],"award-info":[{"award-number":["R00HL121087"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Parker B. Francis Foundation","award":["Fellowship"],"award-info":[{"award-number":["Fellowship"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12931-019-1073-3","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T10:03:51Z","timestamp":1558519431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["It\u2019s more than low BMI: prevalence of cachexia and associated mortality in COPD"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2647-9422","authenticated-orcid":false,"given":"Merry-Lynn N.","family":"McDonald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiel F. M.","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Casaburi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen I.","family":"Rennard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Lomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcas","family":"Bamman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartolome","family":"Celli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvar","family":"Agusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Tal-Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig P.","family":"Hersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Dransfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin K.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,22]]},"reference":[{"key":"1073_CR1","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","volume":"27","author":"WJ Evans","year":"2008","unstructured":"Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD. Cachexia: a new definition. Clin Nutr. 2008;27:793\u20139.","journal-title":"Clin Nutr"},{"key":"1073_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/ajcn\/82.1.53","volume":"82","author":"AM Schols","year":"2005","unstructured":"Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am. J. Clin. Nutr. 2005;82:53\u20139.","journal-title":"Am. J. Clin. Nutr"},{"key":"1073_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ijcard.2012.09.213","volume":"161","author":"S von Haehling","year":"2012","unstructured":"von Haehling S, Anker SD. Cachexia as major underestimated unmet medical need: facts and numbers. Int. J. Cardiol. 2012;161:121\u20133.","journal-title":"Int. J. Cardiol"},{"key":"1073_CR4","doi-asserted-by":"crossref","unstructured":"Haehling S Von, Anker MS, Anker SD. Prevalence and clinical impact of cachexia in chronic illness in Europe , USA , and Japan : facts and numbers update 2016. 2016; : 507\u2013509.","DOI":"10.1002\/jcsm.12167"},{"key":"1073_CR5","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa021322","volume":"350","author":"BR Celli","year":"2004","unstructured":"Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005\u201312.","journal-title":"N Engl J Med"},{"key":"1073_CR6","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.rmed.2009.12.017","volume":"104","author":"BR Celli","year":"2010","unstructured":"Celli BR. Predictors of mortality in COPD. Respir Med Elsevier Ltd. 2010;104:773\u20139.","journal-title":"Respir Med"},{"key":"1073_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/MCO.0b013e328300ecc1","volume":"11","author":"BH Tan","year":"2008","unstructured":"Tan BH, Fearon KC. Cachexia: prevalence and impact in medicine. Curr. Opin. Clin. Nutr. Metab. Care. 2008;11:400\u20137.","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"1073_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","volume":"10","author":"K Fearon","year":"2013","unstructured":"Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer cachexia. Nat. Rev. Clin. Oncol. 2013;10:90\u20139.","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"1073_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol Elsevier Ltd. 2011;12:489\u201395.","journal-title":"Lancet Oncol"},{"key":"1073_CR10","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1183\/09031936.00111707","volume":"31","author":"J Vestbo","year":"2008","unstructured":"Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, Silverman EK, Tal-Singer R. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J. 2008;31:869\u201373.","journal-title":"Eur Respir J"},{"key":"1073_CR11","doi-asserted-by":"publisher","first-page":"448.e1","DOI":"10.1016\/j.jamda.2014.03.012","volume":"15","author":"FME Franssen","year":"2014","unstructured":"Franssen FME, Rutten EPA, Groenen MTJ, Vanfleteren LE, Wouters EFM, Spruit MA. New reference values for body composition by bioelectrical impedance analysis in the general population: results from the UK biobank. J Am Med Dir Assoc. 2014;15:448.e1\u20136.","journal-title":"J Am Med Dir Assoc"},{"key":"1073_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1183\/09031936.00104507","volume":"31","author":"CG Cote","year":"2008","unstructured":"Cote CG, Casanova C, Mar\u00edn JM, Lopez MV, Pinto-Plata V, De Oca MM, Dordelly LJ, Nekach H, Celli BR. Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J. 2008;31:571\u20138.","journal-title":"Eur Respir J"},{"key":"1073_CR13","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00520-004-0734-y","volume":"13","author":"S Van Belle","year":"2005","unstructured":"Van Belle S, Paridaens R, Evers G, Kerger J, Bron D, Foubert J, Ponnet G, Vander Steichel D, Heremans C, Rosillon D. Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool. Support Care Cancer. 2005;13:246\u201354.","journal-title":"Support Care Cancer"},{"key":"1073_CR14","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2147\/COPD.S63568","volume":"9","author":"BL Barker","year":"2014","unstructured":"Barker BL, McKenna S, Mistry V, Pancholi M, Patel H, Haldar K, Barer MR, Pavord ID, Steiner MC, Brightling CE, Bafadhel M. Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:975\u201381.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1073_CR15","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1164\/ajrccm\/143.6.1248","volume":"143","author":"AM Schols","year":"1991","unstructured":"Schols AM, Soeters PB, Mostert R, Saris WH, Wouters EF. Energy balance in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1991;143:1248\u201352.","journal-title":"Am Rev Respir Dis"},{"key":"1073_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.resinv.2015.02.004","volume":"53","author":"NA Negewo","year":"2015","unstructured":"Negewo NA, McDonald VM, Gibson PG. Comorbidity in chronic obstructive pulmonary disease. Respir Investig Elsevier. 2015;53:249\u201358.","journal-title":"Respir Investig"},{"key":"1073_CR17","unstructured":"Society for Cachexia, Sarcopenia and Wasting Diseases Website. Definition of cachexia and sarcopenia. \n                    https:\/\/society-scwd.org\/cachexia-definition\/\n                    \n                  . Accessed 18 May 2019."},{"key":"1073_CR18","unstructured":"Lavie CJ, De Schutter A, Milani R V. Healthy obese versus unhealthy lean: the obesity paradox. Nat. Rev. Endocrinol. 2015;11(1):55-62."},{"key":"1073_CR19","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1164\/ajrccm.160.6.9902115","volume":"160","author":"C Landbo","year":"1999","unstructured":"Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999;160:1856\u201361.","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"1073_CR20","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1177\/1359105315618000","volume":"22","author":"K Buchanan","year":"2017","unstructured":"Buchanan K, Sheffield J. Why do diets fail? An exploration of dieters\u2019 experiences using thematic analysis. J Health Psychol. 2017;22:906\u201315.","journal-title":"J Health Psychol"},{"key":"1073_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1037\/a0030849","volume":"120","author":"W Stroebe","year":"2013","unstructured":"Stroebe W, van Koningsbruggen GM, Papies EK, Aarts H. Why most dieters fail but some succeed: a goal conflict model of eating behavior. Psychol Rev. 2013;120:110\u201338.","journal-title":"Psychol Rev"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1073-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-019-1073-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1073-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T19:29:43Z","timestamp":1590002983000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-019-1073-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,22]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1073"],"URL":"https:\/\/doi.org\/10.1186\/s12931-019-1073-3","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,22]]},"assertion":[{"value":"12 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All analyses were performed after obtaining approval from the Institutional Review Board of the University of Alabama at Birmingham.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M-LNM reports grants from National Institutes of Health, other from Parker B. Francis Foundation, during the conduct of the study and personal fees from Pfizer, outside the submitted work.EFMW has received personal fees from Nycomed, Boehringer, AstraZeneca, GSK, Novartis and Chiesi. EFMW has received grants from AstraZeneca and GSK.ER has no competing interests.RC has received personal fees from GSK, Boehringer Ingelheim, Astra Zeneca, Genentech and Regeneron.SIR reports other from AstraZeneca, outside the submitted work. S.I.R. is employed by AstraZeneca.DAL reports grants, personal fees and non-financial support from GSK during the conduct of the study and personal fees from Griffols, outside the submitted work.MB has no competing interests.BC reports personal fees and other from Astra Zeneca, personal fees from GlaxoSmithKline, personal fees from Boehringer Ingelheim, personal fees from Novartis, personal fees from Sanofi Aventis and personal fess form Menarini other from outside the submitted work.AA reports personal fees from GSK, during the conduct of the study.RT-S is an employee and shareholder of GSK, the ECLIPSE study sponsor.CPH reports personal fees from Mylan, personal fees from AstraZeneca, personal fees from Concert Pharmaceuticals, personal fees from 23andMe, grants from Novartis, grants from Boehringer-Ingelheim, grants from NHLBI, outside the submitted work.MD reports grants from Department of Defense, personal fees and other from Boehringer Ingelheim, personal fees and other from GSK, other from Novartis, personal fees and other from AstraZeneca, other from Yungjin, personal fees and other from PneumRx\/BTG, other from Pulmonx, personal fees from Genentech, personal fees and other from Boston Scientific, personal fees from Quark Pharmaceuticals, grants from NIH, outside the submitted work.EKS reports grants, personal fees and other from GSK, during the conduct of the study; personal fees from Novartis, outside the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"100"}}